Cutaneous leishmaniasis is endemic in parts of Saudi Arabia. Levamisole used as a stimulant of cell mediated immunity has been shown in this study to produce good therapeutic response in clinical trials in the chronic form of this disease. Levamisole may prove to be the treatment of choice in the chronic form of Leishmania tropica.